Comparison of Injection Approaches for Ultrasound-Guided Subacromial Steroid Injection

Comparison of Procedural Pain and Clinical Outcomes between Caudal and Cranial Approaches for Ultrasound-Guided Subacromial-Subdeltoid Bursa Steroid Injection: A Prospective, Single-Blinded, Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0012011

Enrollment

Registered

2026-05-20

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Procedure/Surgery : The intervention in this study is an ultrasound-guided subacromial-subdeltoid bursa steroid injection. All subjects will receive a single injection of the same drug mixture (

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 19 to 80 years. 2. Diagnosed with subacromial bursitis or rotator cuff tendinosis/partial-thickness tear based on clinical and ultrasound findings. 3. Scheduled to receive an ultrasound-guided subacromial-subdeltoid bursa steroid injection. 4. Fully understood the purpose and methods of this study and voluntarily provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with full-thickness rotator cuff tears. 2. History of surgical treatment on the affected shoulder. 3. Concomitant adhesive capsulitis with significant restriction of range of motion. 4. Received a steroid injection in the affected shoulder within the last 3 months. 5. Uncontrolled diabetes mellitus (HbA1c > 9.0%). 6. History of allergy to local anesthetics or steroids. 7. Pregnant or breastfeeding women. 8. Local infection at the injection site.

Design outcomes

Primary

Measure	Time frame
Procedural pain (Insertion pain and Instillation pain measured by NRS 0-10)	—

Secondary

Measure	Time frame
Changes in shoulder pain and functional scores (VAS, ASES score, Constant-Murley Score);Procedure time and needle pass count;Incidence of adverse events and complications (e.g., steroid flare, infection, skin depigmentation)	—

Countries

Korea, Republic of

Contacts

Public ContactJaemin Lee

Yonsei University, Wonju Severance Christian Hospital

megatal12@yonsei.ac.kr+82-33-741-1357

Outcome results